Publications
Export 91 results:
Filters: Author is Roy, Marc-André [Clear All Filters]
, “Replication of linkage with bipolar disorder on chromosome 16p in the Eastern Quebec population.”, Am J Med Genet B Neuropsychiatr Genet, vol. 147B, no. 6, pp. 737-44, 2008.
, “[Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it].”, Sante Ment Que, vol. 32, no. 1, pp. 299-315, 2007.
, “Informative phenotypes for genetic studies of psychiatric disorders.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 5, pp. 581-8, 2007.
, “Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.”, Am J Med Genet B Neuropsychiatr Genet, vol. 144B, no. 8, pp. 1063-9, 2007.
, “Processing spatial-temporal information in recent-onset schizophrenia: the study of short-term memory and its susceptibility to distraction.”, Brain Cogn, vol. 64, no. 3, pp. 201-7, 2007.
, “A comment on "Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis" from a cognitive neuropsychological perspective.”, Schizophr Res, vol. 84, no. 1, pp. 170-1, 2006.
, “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.
, “A pilot feasibility study of an extension of the acquaintanceship recruitment procedure in recent-onset psychosis.”, J Nerv Ment Dis, vol. 193, no. 8, pp. 560-3, 2005.
, “Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.”, J Clin Psychiatry, vol. 65, no. 4, pp. 557-64, 2004.
, “A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translation.”, J Nerv Ment Dis, vol. 192, no. 12, pp. 864-7, 2004.
, “Fine motor dexterity is correlated to social functioning in schizophrenia.”, Schizophr Res, vol. 62, no. 3, pp. 269-73, 2003.
, “[Genetics of schizophrenia and bipolar disorder: recent success of linkage studies with evidence of specific and shared susceptibility loci].”, Med Sci (Paris), vol. 19, no. 10, pp. 960-6, 2003.
, “A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia.”, Schizophr Res, vol. 62, no. 1-2, pp. 155-63, 2003.
, “Chromosome 1q12-q22 linkage results in eastern Québec families affected by schizophrenia.”, Am J Med Genet, vol. 114, no. 1, pp. 51-5, 2002.
, “Quantifying dimensions in autism: a factor-analytic study.”, J Am Acad Child Adolesc Psychiatry, vol. 41, no. 4, pp. 467-74, 2002.
, “Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group.”, J Clin Psychopharmacol, vol. 20, no. 3, pp. 295-304, 2000.
